Posters

Filters

Clear Filters

Sunday, September 28

4:45 PM - 6:00 PM PT
4:45 PM - 6:00 PM PT

2412 - Screening of the Population Benefiting from Postoperative Radiotherapy in Resectable Stage III-N2 NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy

Speaker: Li, Min - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong
4:45 PM - 6:00 PM PT

2413 - Identification of Radioresistance Biomarkers Using Surface-Enhanced Raman Scattering (SERS) Molecular Diagnosis and Multi-Omics in NSCLC Cells

Speaker: Li, Nan, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, China, Chongqing
4:45 PM - 6:00 PM PT

2414 - Induction Chemotherapy Administration Increases the Risk of Radiation Pneumonitis in Unresectable Stage III NSCLC Patients Undergoing Concurrent Chemoradiotherapy with Immunotherapy

Speaker: Li, Pengwei, MS - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong
4:45 PM - 6:00 PM PT

2415 - Low-Dose Radiotherapy Enhances the Antitumor Immunity of ISABR in Non-Small Cell Lung Cancer

Speaker: Li, Ziye, MD - First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui
4:45 PM - 6:00 PM PT

2416 - Salvage Proton Therapy after Primary Cryosurgery or HIFU for Prostate Cancer

Speaker: Lichlyter, Daniel, BS - University of Florida College of Medicine, Department of Radiation Oncology, Gainesville, FL